Shilajit vs Cordyceps: An Honest Comparison

|ShilNepal

Shilajit vs Cordyceps: An Honest Comparison

Both shilajit and cordyceps come from high-altitude environments and carry centuries of traditional use, which is partly why they get compared so often. What they actually are, and what real human trials support, is quite different. This comparison covers what each has genuine evidence for, and a real complication with cordyceps worth knowing before you buy: what is actually in the jar often is not what the name implies.

Key takeaways

  • Most commercial "cordyceps" products contain a fermented substitute organism, not the wild fungus traditional medicine describes, which matters for comparing studies to products.
  • The one trial using a pure, standard cordyceps extract in trained athletes found no performance benefit, contradicting a very common marketing claim.
  • Cordyceps' widely repeated libido statistic could not be traced to a real, citable study. Treat it as unverified.

What each one is, and a naming problem worth knowing

Shilajit is a mineral-rich resin that exudes from Himalayan rock formations, used in Ayurvedic medicine. Cordyceps traditionally refers to Ophiocordyceps sinensis, a fungus that grows on moth larvae on the Tibetan Plateau, used in Traditional Chinese and Tibetan medicine as a "kidney and lung tonic." Wild cordyceps is extremely expensive and scarce. Because of this, the overwhelming majority of commercial cordyceps supplements actually contain fermented mycelium of a different, related organism (commonly sold as "Cs-4"), or cultivated Cordyceps militaris, a distinct species typically higher in the compound cordycepin. This is a genuine, documented substitution in the supplement industry, not a minor technicality, because it means a study on one cordyceps product does not automatically apply to another with a different organism inside.

Exercise performance: weaker than the marketing suggests

This is the area where cordyceps marketing is most confident and the evidence is, honestly, the least convincing. A placebo-controlled trial in trained cyclists using a standardised Cs-4 extract over 5 weeks found no effect on VO2 peak, ventilatory threshold, or time-trial performance. A separate 12-week trial in healthy older adults found improvements in metabolic and ventilatory threshold but explicitly no change in VO2 max in either group. A third trial found a benefit after 3 weeks, but used a multi-mushroom blend rather than cordyceps alone, and only 10 of 28 participants completed that arm of the study.

Shilajit's own exercise evidence, from an unrelated research group, found a branded extract helped preserve muscular strength after a fatigue protocol in young, fit men over 8 weeks. Neither herb has strong, broad exercise-performance evidence, but the one trial testing pure cordyceps in genuinely trained athletes returned a null result, which is worth knowing if that is specifically why you are considering it.

Immune markers: real, but more complicated than "boosts immunity"

This is cordyceps' most genuinely evidenced area. A placebo-controlled trial in 79 healthy adults using pure Cordyceps militaris over 4 weeks found significant increases in natural killer cell activity and several immune signalling markers. That is real, verified human trial data.

It is not the whole picture. A separate laboratory study using human immune cells found the opposite direction of effect, an immune-suppressing action on a different cell type. Taken together, this suggests cordyceps' effect on the immune system is more context-dependent than a simple "boosts immunity" claim implies, and the human trial that does exist measured immune cell activity and signalling markers, not clinical outcomes like fewer colds or better vaccine response, which is a different and stronger claim than the data actually supports.

A real trial found cordyceps increased immune cell activity in healthy adults. That is meaningfully different from proving it prevents illness, which is not what this trial, or any trial we could locate, actually measured.

Libido and kidney tonic claims: the traditional claim that would not check out

Cordyceps' reputation as a libido and vitality tonic traces to Traditional Chinese Medicine's "kidney-yang" framework. A specific statistic circulates widely online, describing a large improvement in sexual function in one group compared with others. We searched directly for the original study behind this figure and could not trace it to a real, identifiable author, journal, or trial record. This is exactly the pattern worth being suspicious of: a specific-sounding number with no findable source behind it. We are not using it here, and would treat it as unverified marketing claim rather than evidence until a primary source can be confirmed. No verified human trial on cordyceps and testosterone was located either; what exists is animal and cell-level data only. Shilajit, by contrast, does have one real human testosterone trial, detailed in our full evidence review.

Safety

Because cordyceps can stimulate immune activity, some clinicians caution against it for people with autoimmune conditions, though this is a precaution based on plausible mechanism rather than demonstrated harm in a controlled trial. Cordyceps may also interact with immunosuppressant medication and has mild reported anticoagulant activity, making it worth a conversation with a healthcare professional before surgery or if you take blood-thinning medication. Shilajit's main documented safety issue is different: heavy metal risk in unpurified raw resin, which is why independent, batch specific testing matters more than a marketing claim. See our full shilajit safety guide.

Comparison table

Claim area Shilajit Cordyceps
Exercise performance Human RCT one trial, young fit men Mostly null pure extract, trained athletes, no effect
Immune markers Not a primary claim area in current evidence Human RCT real increase in immune cell activity
Testosterone / libido Human RCT one trial, unreplicated Unverified claim no traceable human trial found
Kidney disease markers Not studied Cochrane review 22 trials, disease population, low certainty evidence

The honest verdict

Cordyceps has one genuinely solid human trial on immune cell activity in healthy adults, which shilajit's current evidence base does not have an equivalent for. Its exercise-performance reputation is weaker than commonly marketed, with the one trial in trained athletes returning a null result. Its libido claim rests on an unverifiable statistic. Shilajit's narrower evidence base includes a real testosterone trial cordyceps cannot currently match. Whichever you consider, check what organism is actually inside the product you are looking at, since "cordyceps" on a label does not guarantee it matches what was tested in any given study.

FAQ

Is the cordyceps in supplements the same as the traditional Chinese medicine ingredient?

Usually not exactly. Most commercial products use a fermented substitute organism or a different, cultivated species, rather than the wild fungus traditional medicine describes.

Does cordyceps really boost athletic performance?

The best available trial using a pure, standard extract in trained cyclists found no effect on endurance measures. Evidence for a performance benefit is weaker than commonly marketed.

Is the libido claim for cordyceps real?

The specific statistic commonly repeated could not be traced to a real, citable study in our research. Treat it as unverified.

References

  1. Parcell AC, et al. Int J Sport Nutr Exerc Metab. 2004;14(2):236 to 242. PMID 15118196.
  2. Chen S, et al. J Altern Complement Med. 2010;16(5):585 to 590. PMID 20804368.
  3. Hirsch KR, et al. J Diet Suppl. 2017;14(1):42 to 53. PMID 27408987.
  4. Kang HJ, et al. J Med Food. 2015;18(10):1164 to 1172. PMID 26284906.
  5. Tang J, et al. Am J Chin Med. 2010;38(5):961 to 972. PMID 20821826.
  6. Zhang HW, et al. Cochrane Database Syst Rev. 2014;CD008353. PMID 25519252.
  7. Pandit S, et al. Andrologia. 2016;48(5):570 to 575. DOI: 10.1111/and.12482.
  8. Keller JL, et al. J Int Soc Sports Nutr. 2019;16(1):3.

Some figures above are drawn from published abstracts rather than full text where publisher access was restricted; noted transparently in our internal research record.

Related Reading